204 related articles for article (PubMed ID: 22870217)
1. Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma.
Saini V; Hose CD; Monks A; Nagashima K; Han B; Newton DL; Millione A; Shah J; Hollingshead MG; Hite KM; Burkett MW; Delosh RM; Silvers TE; Scudiero DA; Shoemaker RH
PLoS One; 2012; 7(8):e41401. PubMed ID: 22870217
[TBL] [Abstract][Full Text] [Related]
2. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
[TBL] [Abstract][Full Text] [Related]
3. Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells.
Yang M; Yan M; Zhang R; Li J; Luo Z
Cancer Sci; 2011 Oct; 102(10):1774-81. PubMed ID: 21740477
[TBL] [Abstract][Full Text] [Related]
4. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.
Di Fiore R; Santulli A; Ferrante RD; Giuliano M; De Blasio A; Messina C; Pirozzi G; Tirino V; Tesoriere G; Vento R
J Cell Physiol; 2009 May; 219(2):301-13. PubMed ID: 19160414
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice.
Skoda J; Nunukova A; Loja T; Zambo I; Neradil J; Mudry P; Zitterbart K; Hermanova M; Hampl A; Sterba J; Veselska R
Tumour Biol; 2016 Jul; 37(7):9535-48. PubMed ID: 26790443
[TBL] [Abstract][Full Text] [Related]
6. Detection of tumor stem cell markers in pancreatic carcinoma cell lines.
Olempska M; Eisenach PA; Ammerpohl O; Ungefroren H; Fandrich F; Kalthoff H
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):92-7. PubMed ID: 17287174
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
8. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
[TBL] [Abstract][Full Text] [Related]
9. Salinomycin inhibits osteosarcoma by targeting its tumor stem cells.
Tang QL; Zhao ZQ; Li JC; Liang Y; Yin JQ; Zou CY; Xie XB; Zeng YX; Shen JN; Kang T; Wang J
Cancer Lett; 2011 Dec; 311(1):113-21. PubMed ID: 21835542
[TBL] [Abstract][Full Text] [Related]
10. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.
Mitra M; Kandalam M; Harilal A; Verma RS; Krishnan UM; Swaminathan S; Krishnakumar S
Mol Vis; 2012; 18():290-308. PubMed ID: 22328825
[TBL] [Abstract][Full Text] [Related]
11. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas.
Li F; Zeng H; Ying K
Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cancer stem cell antigen expression by tumor cell lines and by tumor biopsies from dogs with melanoma and osteosarcoma.
Guth AM; Deogracias M; Dow SW
Vet Immunol Immunopathol; 2014 Oct; 161(3-4):132-40. PubMed ID: 25146881
[TBL] [Abstract][Full Text] [Related]
14. Correlation of IGF1R expression with ABCG2 and CD44 expressions in human osteosarcoma.
Kim CK; Oh S; Kim SJ; Leem SH; Heo J; Chung SH
Genes Genomics; 2018 Apr; 40(4):381-388. PubMed ID: 29892839
[TBL] [Abstract][Full Text] [Related]
15. Endosialin‑expressing bone sarcoma stem‑like cells are highly tumor‑initiating and invasive.
Sun DX; Liao GJ; Liu KG; Jian H
Mol Med Rep; 2015 Oct; 12(4):5665-70. PubMed ID: 26300407
[TBL] [Abstract][Full Text] [Related]
16. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.
Costa CD; Justo AA; Kobayashi PE; Story MM; Palmieri C; Laufer Amorim R; Fonseca-Alves CE
Int J Biochem Cell Biol; 2019 Mar; 108():21-28. PubMed ID: 30633985
[TBL] [Abstract][Full Text] [Related]
17. Characterization of stem cell attributes in human osteosarcoma cell lines.
Wang L; Park P; Lin CY
Cancer Biol Ther; 2009 Mar; 8(6):543-52. PubMed ID: 19242128
[TBL] [Abstract][Full Text] [Related]
18. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG
Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
